Back
Lucid Diagnostics 10K Form
Sell
48
LUCD
Lucid Diagnostics
Last Price:
$1.53
Seasonality Move:
0.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LUCD News And Ratings
See the #1 stock for the next 7 days that we like better than LUCD
LUCD Financial Statistics
Sales & Book Value
| Annual Sales: | $4.3M |
|---|---|
| Cash Flow: | $-12.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.71 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.20000 |
|---|---|
| Net Income (TTM): | $-61.8M |
| Gross Margin: | $-2.8M |
| Return on Equity: | -903.21% |
| Return on Assets: | -203.01% |
Lucid Diagnostics Earnings Forecast
Key Lucid Diagnostics Financial Ratios
-
The Gross Profit Margin over the past 5 years for LUCD is -63.35%.
-
The Selling, General & Administrative Expenses for LUCD have been equal to 842.59% of Gross Profit Margin.
-
The Research & Development expenses have been 137.87% of Revenue.
-
The Net Earning history of LUCD is -1,047.61% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Lucid Diagnostics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LUCD |
| Website: | luciddx.com |
Debt
| Debt-to-Equity Ratio: | -6.1 |
|---|---|
| Current Ratio: | 0.75 |
| Quick Ratio: | 0.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LUCD Technical Analysis vs Fundamental Analysis
Sell
48
Lucid Diagnostics (LUCD)
is a Sell
Is Lucid Diagnostics a Buy or a Sell?
-
Lucid Diagnostics stock is rated a SellThe current Lucid Diagnostics [LUCD] share price is $1.52. The Score for LUCD is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.